rss
Br J Ophthalmol 88:953-956 doi:10.1136/bjo.2003.032979
  • Laboratory science - Scientific reports

Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension

Table 5

 Unsolicited systemic adverse events (number of subjects with such an event; two or more events indicated)

Brimonidine purite Dorzolamide p Value
Bitter taste upon instillation 1 3 0.25
Benign prostatic hyperplasia 1 1 >0.999
Left leg injury 1 1 >0.999
Non-insulin dependent diabetes 1 1 >0.999
Worsening of osteoarthritis 1 1 >0.999

This Article

  1. Abstract
  2. Full text
  3. PDF

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.